Pharma Manufacturing provides information and resources related to the pharmaceutical manufacturing sector, including industry news, articles, and events.

Pharma Manufacturing

Takeda is a global pharmaceutical leader that focuses on serving the needs of patients and physicians. The company is involved in various therapeutic areas including gastroenterology, oncology, rare diseases, and immunology. This is self-described.

Takeda

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.

Siegfried Holding AG

AAA Pharmaceutical Inc manufactures over-the-counter solid dose pharmaceuticals, focusing on product quality and regulatory compliance.

Metric
Company Name	Pharma Manufacturing	Takeda	Siegfried Holding AG	AAA Pharmaceutical Inc
Symbol			SFZN
MSH ID	COM:PHARMAMANUFACTURING	BE:TAKEDA	CH:SIEGFRIED	COM:AAAPHARM
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Commercial & Professional Services	Healthcare & Health Services		Healthcare & Health Services
Industry	Pharmaceuticals	Pharmaceuticals		Pharmaceutical Manufacturing
Country	US	BE	CH	US
Stage
Employee Count			3.63K
Website	pharmamanufacturing.com	takeda.be	siegfried.ch	aaapharm.com
LinkedIn
Founders

Metric
Market Cap			4.14B
Enterprise Value
Monthly Web Traffic	6.54K	825.79K
Web Traffic Growth	-0.82	-0.01
Valuation
Raised Capital		19.80M

Metric
Revenue			1.45B
Revenue (LTM)
Revenue (NTM)
Gross Profit			365.24M
EBITDA			270.88M
Operating Income			196.14M
Net Income			128.55M
EPS			30.33
Diluted EPS			29.89
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.26
Operating Profit Margin			0.14
EBITDA Margin			0.19
Net Profit Margin			0.10
Return on Equity			0.15
Return on Assets			0.07
Return on Capital Employed			0.12

COM:PHARMAMANUFACTURING

Pharma Manufacturing

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			22.59
P/B Ratio			4.47
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			3.95
EV Multiple			17.63

Metric
Days Sales Outstanding			127.47
Days Payables Outstanding			45.72
Days Inventory Outstanding			178.19
Operating Cycle			304.80
Cash Conversion Cycle			266.86
Asset Turnover			0.68

Metric
Operating Cash Flow			237.80M
Free Cash Flow			81.52M
Cash Flow to Debt			0.57
Operating Cash Flow/Sales			0.19
Free Cash Flow Yield			0.01

Metric
Cash & Equivalents			64.25M
Accounts Receivable			-20.29M
Inventory			492.38M
Goodwill
Debt to Capitalization			0.36
Debt to Assets
Current Ratio			2.98
Quick Ratio			1.40

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.01
R&D to Revenue			0.04
SG&A to Revenue			0.03